Abu Dhabi approves new COVID medication

iStock [For illustration]

A new COVID-19 medication has been approved in Abu Dhabi for the treatment of mild to moderate cases and those who have had direct contact with a patient.

The emirate's Department of Health (DoH) has partnered with Swiss healthcare company Roche to provide casirivimab and imdevimab to certain categories of patients.

The antibody combination has already been approved in the European Union and Japan, and conditionally approved in the UK and Australia.

It is also authorised for emergency use in the United States, India, Switzerland and Canada, and is recommended by the World Health Organisation (WHO).

More from Local News

News

  • H.H. Sheikh Hamdan pays tribute to royal photographer

    His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and the UAE's Deputy Prime Minister and Defence Minister, has offered his heartfelt condolences to the family of royal photographer Ramesh Shukla, who passed away on Sunday.

  • H.H. Sheikh Hamdan awards Arab Hope Makers

    His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and the UAE's Deputy Prime Minister and Defence Minister, has awarded Morocco's Fouzia Jbara Mahmoudi with AED1 million as the top winner of the Arab Hope Maker initiative on Sunday.

  • UAE looks into framework to regulate children's social media use

    The UAE's Education, Human Development, and Community Development Council is working towards establishing a framework that will regulate the use of social media among children.